Dicato M - Search Results

1

Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancer.

Ries F, Duhem C, Kleiber K, Dicato M. Ries F, et al. Among authors: dicato m. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-48-S17-51. Semin Oncol. 1997. PMID: 9374093 Clinical Trial.

2

Treatment of advanced and refractory breast cancer with doxorubicin, vincristine and continuous infusion of verapamil. A phase I-II clinical trial.

Ries F, Dicato M. Ries F, et al. Among authors: dicato m. Med Oncol Tumor Pharmacother. 1991;8(1):39-43. doi: 10.1007/BF02988570. Med Oncol Tumor Pharmacother. 1991. PMID: 2041381 Clinical Trial.

3

Epirubicin cardiotoxicity: a study comparing low- with high-dose-intensity weekly schedules.

Berchem GJ, Ries F, Hanfelt J, Duhem C, Keipes M, Delagardelle C, Dicato M. Berchem GJ, et al. Among authors: dicato m. Support Care Cancer. 1996 Jul;4(4):308-12. doi: 10.1007/BF01358886. Support Care Cancer. 1996. PMID: 8829311

4

The biology of colorectal cancer.

Dicato M, Berchem G, Duhem C, Ries F. Dicato M, et al. Semin Oncol. 2000 Oct;27(5 Suppl 10):2-9. Semin Oncol. 2000. PMID: 11049027 Review. No abstract available.

5

Side-effects of intravenous immune globulins.

Duhem C, Dicato MA, Ries F. Duhem C, et al. Among authors: dicato ma. Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):79-83. Clin Exp Immunol. 1994. PMID: 8033440 Free PMC article. Review.

6

[Apoptosis and cancer].

Duhem C, Ries F, Dicato M. Duhem C, et al. Among authors: dicato m. Bull Soc Sci Med Grand Duche Luxemb. 1994;131(1):39-48. Bull Soc Sci Med Grand Duche Luxemb. 1994. PMID: 8050118 Review. French. No abstract available.

7

[Chemoprevention: a new strategy in the fight against breast cancer?].

Bercheme G, Ries F, Dicato M. Bercheme G, et al. Among authors: dicato m. Bull Soc Sci Med Grand Duche Luxemb. 1993;130(1):5-9. Bull Soc Sci Med Grand Duche Luxemb. 1993. PMID: 8222016 French. No abstract available.

8

Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial.

Focan C, Andrien JM, Closon MT, Dicato M, Driesschaert P, Focan-Henrard D, Lemaire M, Lobelle JP, Longree L, Ries F. Focan C, et al. Among authors: dicato m. J Clin Oncol. 1993 Jul;11(7):1253-63. doi: 10.1200/JCO.1993.11.7.1253. J Clin Oncol. 1993. PMID: 8315422 Clinical Trial.

9

[Resistance to chemotherapy: current therapeutic approach].

Ries F, Pauly M, Poeckes L, Duhem C, Dicato M. Ries F, et al. Among authors: dicato m. Bull Soc Sci Med Grand Duche Luxemb. 1995;132(3):19-26. Bull Soc Sci Med Grand Duche Luxemb. 1995. PMID: 8665621 Review. French. No abstract available.

10

Multidrug resistance: molecular and clinical aspects.

Dicato M, Duhem C, Pauly M, Ries F. Dicato M, et al. Cytokines Cell Mol Ther. 1997 Jun;3(2):91-9. Cytokines Cell Mol Ther. 1997. PMID: 9287248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters